BioSpace News Archive

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage.

The rising chronic condition incidences and growing demand for tissue engineering processes and regenerative medicine are driving the demand for the market.

A revolutionary temperature and pressure (TAP) sensing insole for diabetics, created by XtremedX, was recently named a TOP 20 New Diabetic Device for 2022 by the Diabetes Center Berne (DCB) in Berne, Switzerland.

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that new analyses from IBSRELA Phase 3 trials, T3MPO-1 and T3MPO-2, were presented in three poster presentations at the 2022 Digestive Disease Week Conference.

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication (ACI) and substance abuse disorder (the “Company” or “Anebulo”), today announced the appointment of Dr. Kenneth Cundy, Ph.D. as Chief Scientific Officer of the Company.

Increasing prevalence of various chronic diseases and rising demand for remote patient monitoring due to high elderly population are key factors driving global market revenue growth

Increasing aging population and higher adoption of early diagnosis and treatment are key factors boosting global market revenue growth

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.61 billion for the second quarter ended April 30, 2022, an increase of 5% compared to the second quarter of 2021 and up 7% on a core(1) basis.

Increasing demand for gluconic acid in various end-use industries including food & beverage, personal care, and agriculture industries is expected to drive market growth

The latest market report presented by Reports and Data, titled “Antibody Services Market By Service Type (Development, Production & Purification, Fragmentation & Labelling), By Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Others), By Source (Mice, Rabbits, Others), By Research Area, By End-use, and By Region Forecast to 2028,” is inclusive of crucial data & information pertaining to the global Antibody Services market.